Exogen Biotechnology, Inc.

Exogen Biotechnology is a Berkeley-based healthcare startup dedicated to quantifying DNA damage and assessing cellular DNA repair capacities. Over 40% of the US population will be diagnosed with cancer and doctors desperately need a way to identify at risk cancer patients and stratify cancer patients for various treatment options. Exogen Bio has developed a technology capable of identifying novel DNA prognostic markers that allows clinicians to better prevent and treat cancer.

Green Resource Co

Core business of our Company is to produce/extract bio materials from animals organs, trading of textile waste and fish items. Our aim is to provide state of the art products/services to our valued customers at competitive cost and within time limits. Maintaining best quality of the products and honesty are core values of our company´s policy to keep our customer happy.

CAT Scientific

CAT Scientific distributes a variety of advanced laboratory equipment for pharmaceutical, chemical, and good industry laboratories. High quality equipment including homogenizer drives, magnetic hotplate stirrers, overhead stirrers, and liquid handling contiburettes. More recently, CAT Scientific has been working with many startups in the field of cannabis extracts, offering assistance in the challenges of obtaining stability when decarboxylating cannabis extracts, working with acidic cannabinoids and emulsifying extracts. The more advanced laboratory equipment is critical to creating stability in the products created from these elements.

FACIT

FACIT is a business accelerator and investor established by the Ontario Institute for Cancer Research (OICR) to support the commercialization of Ontario breakthrough cancer innovations that benefit patients, researchers, investors and the province's economy.

Bioinova, s.r.o.

Production of therapeutically acting cell lines (somatocellular therapy) under the GMP regulations, FDF - final dosage forms, project management and development in GMP. Currently running and/or preparing multiple clinical trials with mesenchymal stem cells. Contractual manufacturing GMP.